The multinational pharmaceutical company will be presenting its latest innovations in two of the world’s most influential aesthetic medical conferences.

At IMCAS, Dr Sabine Zenker, Dr Philippe Garcia, and Dr Fernando Galcerán will be presenting the latest results of studies carried out with the brand’s intradermal solutions

Barcelona, January 2018 –  mesoestetic Pharma Group will be taking part at IMCAS Paris and AAD San Diego, two of the world’s leading aesthetic medical conferences.

Attendees at IMCAS, taking place in Paris from 1 to 3 February, will learn about the renovated dermamelan® method, which incorporates new solutions that make the world’s leading depigmentation treatment for medical use even more effective. To explain the new method in more detail, Dr Zenker will be giving a live demonstration to show the effects of these coadjuvants on a patient treated with dermamelan® the day before, emphasising the importance of using the home treatment to improve and protect the results.

mesoestetic will also be showcased at the conference’s training village, where three renowned international doctors will be explaining the latest advances and studies carried out with the laboratory’s injectables.

  • Dr Sabine Zenker, an authority on rejuvenation, and non-invasive and micro-invasive treatments will be presenting the study “Aged hands treatment with mesofiller® and mesohyal™”, an approach to hand rejuvenation with a unique combination of mesofiller®, cross-linked HA with mesohyal™, a solution rich in polynucleotides, such as sodium deoxyribonucleate, vitamins, amino acids, mineral salts, and non-cross-linked hyaluronic acid.
  • Dr Philippe Garcia, a specialist in plastic, reconstructive, and cosmetic surgery, will be sharing his study Dark circles with mesofiller® and mesohyal™, an innovative treatment for the dark circles with mesofiller® and mesohyal™ with action on two levels: filling at a deeper level and nourishing more superficially. Thus, the treatment has an indirect action on the eye bags, which are eventually softened as per the filling of the cavity.
  • Dr Fernando Galcerán, a specialist in cosmetic medicine and a collaborator at mesoestetic Pharma Group’s Medical Unit, will be presenting the study “Mirror-lift® and mesobooster®. New facial rejuvenation”, in which he will analyse the effectiveness of the “Mirror-lift® and mesobooster®” protocol, developed to achieve the recovery of the facial oval modified by ptosis and atrophies or hypotrophies of the tissues by the administration of mesoestetic’s mesofiller® and mesohyal™.

At ADD, which takes place in San Diego between 16 and 20 February, the company will be mainly focusing its strength on presenting the new cosmelan® method which, such as the new dermamelan®, incorporates new solutions that improve and increase the effectiveness of this depigmenting treatment of reference among beauticians, with great demand in America.

mesoestetic Pharma Group

mesoestetic Pharma Group is an internationally recognised pharmaceutical laboratory in the field of dermocosmetics and aesthetic medicine. With its headquarters in Viladecans (Barcelona), it develops, produces and markets extremely effective treatments endorsed by scientific studies. Its manufacturing and control processes adhere to the exacting standards of the pharmaceutical industry. Thanks to the effectiveness of its products and its 30+ years of experience, doctors, cosmetic professionals and end users all over the world –including big international stars– place their trust in mesoestetic®.